Australian manufacturer acquired by capital investment firm with experience in CDMO space
An Australian CDMO is looking at a new name and new horizons as a capital investment firm has acquired it.
Luina Bio, based in Darra, Australia, a suburb of Brisbane, has been acquired by Ampersand Capital Partners, a health-centered private equity firm that has experience in the CDMO arena, and by Glenn Haifer, a biotech investor and chairman of the board at Luina.
The acquisition, for which the financial details were not given to Endpoints News, will see the company rebrand and change its name to AcuraBio. In an email to Endpoints, Ampersand Capital stated that it acquired the company because of its potential and scientific experience.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.